In the article “Secrecy Orders for U.S. Patent Applications —An Overview,” published in Reuters Westlaw, attorneys Ryan Freedman, Tom Cowan, and Vlad Teplitskiy provide an overview of secrecy orders –…
In the latest installment of their monthly column focused on recent noteworthy Federal Circuit decisions, partners Jeremiah Helm and Sean Murray examine the implications of the court’s ruling in Telefonaktiebolaget LM Ericsson v. Lenovo (United States)…
In the latest installment of their Law360 column on notable Federal Circuit decisions, partners Sean Murray and Jeremiah Helm analyze the outcome of a recent ruling in AlexSam Inc. v….
In the Law360 article “How 2 Proposed Bills Could Transform Patent Law,” partner Philip Nelson writes about the potential impact of two pieces of legislation that could affect patent law:…
In the Daily Journal article “How Generative AI is Impacting Trade Secret Protection,” partners Daniel Hughes and Adam Powell explore the ways in which generative AI poses new challenges and…
Writing in Reuters Westlaw Today, attorneys Douglas Wentzel and Joshua Martineau offer an overview of § 325(d) petition practice, an important but often overlooked opportunity for patent owners to request that the USPTO discretionarily deny…
In the article “The ‘Deepfake Era’: How To Navigate AI-Generated Content,” attorneys Sheila Swaroop, chair of the firm’s litigation practice, and Sara Witty explore legal protections against AI-generated “deepfakes” and…
In the article “Checking on Supplements: NAD’s Recent Guidance on Substantiating Ingredient vs. Product Claims,” attorneys Jonathan Hyman, Kate McMorrow, and Zoe Vikstrom examine a recent National Advertising Division (NAD)…
In a recent article for the American Intellectual Property Law Association (AIPLA)’s publication Antitrust News, partner Stephen Larson offers insight into initial court challenges to the Federal Trade Commission’s (FTC’s)…
In the MedTech Strategist article “Using Injunctions to Protect MedTech IP,” partner Irfan Lateef and associate Isabella Pestana consider how, when an IP dispute arises, medical device companies can leverage…
